Last updated on July 2016

Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Brief description of study

A phase Ⅲ, multi-center, randomized, double-blinded, placebo and active comparator clinical trial to assess the efficacy and safety of combination therapy of Motireb 5/100 mg in functional dyspepsia patients.

Clinical Study Identifier: NCT02831543


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Nayoung Kim, M.D., Ph.D.

Seoul National University Bundang Hospital
Seong Nam, Korea, Republic of
  Connect »